NYT · Insider Trading
New York Times Co.
Every open-market purchase and sale reported by NYT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-26 | Rachel C Glaser | Director | A | +116 | — |
| 2026-10-26 | Beth A. Brooke | Director | A | +71 | — |
| 2026-10-26 | Anuradha B. Subramanian | Director | A | +38 | — |
| 2026-10-26 | Margot Golden | Director | A | +32 | — |
| 2026-10-26 | Brian P McAndrews | Director | A | +184 | — |
| 2026-10-26 | John W Rogers Jr | Director | A | +111 | — |
| 2026-10-26 | Arthur S. Golden | Director | A | +73 | — |
| 2026-10-26 | Amanpal Singh Bhutani | Director | A | +103 | — |
| 2026-10-26 | Rebecca Van Dyck | Director | A | +184 | — |
| 2026-10-26 | Manuel Bronstein | Director | A | +65 | — |
| 2026-08-13 | William Bardeen | EVP, Chief Financial Officer | F | −485 | −$30.82K |
| 2026-08-12 | David S. Perpich | Director | F | −131 | −$8.32K |
| 2026-07-27 | Brian P McAndrews | Director | A | +176 | — |
| 2026-07-27 | Rachel C Glaser | Director | A | +110 | — |
| 2026-07-27 | John W Rogers Jr | Director | A | +106 | — |
| 2026-07-27 | Rebecca Van Dyck | Director | A | +176 | — |
| 2026-07-27 | Anuradha B. Subramanian | Director | A | +36 | — |
| 2026-07-27 | Beth A. Brooke | Director | A | +68 | — |
| 2026-07-27 | Manuel Bronstein | Director | A | +62 | — |
| 2026-07-27 | Arthur S. Golden | Director | A | +70 | — |
| 2026-07-27 | Amanpal Singh Bhutani | Director | A | +98 | — |
| 2026-07-27 | Margot Golden | Director | A | +31 | — |
| 2026-06-05 | Jacqueline M Welch | EVP and CHRO | Sell | −4,000 | −$296.55K |
| 2026-05-14 | William Bardeen | EVP, Chief Financial Officer | Sell | −4,121 | −$320.82K |
| 2026-05-14 | Levien Meredith A. Kopit | PRESIDENT & CEO | Sell | −9,750 | −$760.50K |
| 2026-05-12 | David S. Perpich | Director | MIXED | −9,500 | −$693.54K |
| 2026-04-24 | Rebecca Van Dyck | Director | A | +2,277 | — |
| 2026-04-24 | Amanpal Singh Bhutani | Director | A | +2,277 | — |
| 2026-04-24 | Manuel Bronstein | Director | A | +2,277 | — |
| 2026-04-24 | Anuradha B. Subramanian | Director | A | +2,277 | — |
| 2026-04-24 | John W Rogers Jr | Director | A | +2,277 | — |
| 2026-04-24 | Brian P McAndrews | Director | A | +2,277 | — |
| 2026-04-24 | Beth A. Brooke | Director | A | +2,277 | — |
| 2026-04-24 | Rachel C Glaser | Director | A | +2,277 | — |
| 2026-04-24 | Arthur S. Golden | Director | A | +2,277 | — |
| 2026-04-24 | Margot Golden | Director | A | +2,277 | — |
| 2026-04-20 | Rebecca Van Dyck | Director | A | +151 | — |
| 2026-04-20 | Anuradha B. Subramanian | Director | A | +26 | — |
| 2026-04-20 | John W Rogers Jr | Director | A | +88 | — |
| 2026-04-20 | Brian P McAndrews | Director | A | +151 | — |
| 2026-04-20 | Rachel C Glaser | Director | A | +92 | — |
| 2026-04-20 | Beth A. Brooke | Director | A | +54 | — |
| 2026-04-20 | Manuel Bronstein | Director | A | +49 | — |
| 2026-04-20 | Amanpal Singh Bhutani | Director | A | +81 | — |
| 2026-04-20 | Margot Golden | Director | A | +21 | — |
| 2026-04-20 | Arthur S. Golden | Director | A | +56 | — |
| 2026-03-05 | Levien Meredith A. Kopit | PRESIDENT & CEO | Sell | −51,949 | −$4.14M |
| 2026-03-05 | William Bardeen | EVP, Chief Financial Officer | Sell | −13,000 | −$1.03M |
| 2026-03-05 | Arthur G. Sulzberger | Chairman and Publisher | Sell | −13,000 | −$1.04M |
| 2026-03-02 | Jacqueline M Welch | EVP and CHRO | MIXED | +14,237 | −$818.68K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Margot Golden | Director | 1,410,107 | $101.02M |
| Levien Meredith A. Kopit | PRESIDENT & CEO | 219,612 | $15.73M |
| Arthur G. Sulzberger | Chairman and Publisher | 177,163 | $12.69M |
| Arthur S. Golden | Director | 92,502 | $6.63M |
| Diane Brayton | EVP, CHIEF LEGAL OFFICER | 64,665 | $4.63M |
| Brian P McAndrews | Director | 60,358 | $4.32M |
| Rebecca Van Dyck | Director | 57,198 | $4.10M |
| John W Rogers Jr | Director | 54,709 | $3.92M |
| R Anthony Benten | SVP, Treasurer & CAO | 42,227 | $3.03M |
| David S. Perpich | Director | 38,838 | $2.78M |
| Rachel C Glaser | Director | 36,004 | $2.58M |
| Amanpal Singh Bhutani | Director | 32,250 | $2.31M |
| Jacqueline M Welch | EVP and CHRO | 23,873 | $1.71M |
| Beth A. Brooke | Director | 22,238 | $1.59M |
| Manuel Bronstein | Director | 20,470 | $1.47M |
| William Bardeen | EVP, Chief Financial Officer | 14,075 | $1.01M |
| Anuradha B. Subramanian | Director | 11,973 | $857.75K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NYT quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.